PancWest Symposium

UC San Diego Health, in collaboration with the Brenden-Colson Center at Oregon Health & Science University, will host the 2016 PancWest Symposium. This event will focus on pancreatic treatment approaches, new technological clinical trials, scientific innovations, and the latest advances.  West coast investigators focused on pancreatic cancer will all come together to help stimulate new collaborations and address the current obstacles in pancreatic cancer research.  

The symposium is a daylong seminar open to academic and medical professionals, early career scientists, postdoc/fellows, and industry. 

Date, Time and Location:

Saturday, September 24, 2016
7:30 am – 4:30 pm

Moores Cancer Center at UC San Diego Health
Goldberg Auditorium
3855 Health Sciences Drive
La Jolla, CA 92093-1503

Topics Include:

  1. Targeting cancer stem cells to prevent recurrence
  2. Defining and targeting tumor metabolism
  3. Therapeutic targeting of the tumor microenvironment
  4. Reprogramming PDAC cells to quiescence
  5. p53 function and PDAC biology
  6. Tumor cell heterogeneity and drug resistance

Featured Session

Sunil R. Hingornai, MD, PhDTargeting the Pancreas Cancer “Neo-Organ” to Therapeutic Advantage
Sunil R. Hingorani, M.D., Ph.D., Fred Hutchinson Cancer Research Center, is a medical oncologist and cancer biologist specializing in pancreas cancer. His research studies the molecular and cellular pathogenesis of pancreas cancer primarily through the use of genetically engineered mouse models. These animal models of distinct genetic subtypes of pancreas cancer form the basis for an integrated, systematic and multidisciplinary program of study. For more information, click here.

Other Sessions


  • Session 1: Stem Cells, Reprogramming and Cellular Plasticity
    • Targeting cancer stem cells to prevent disease relapse in pancreatic cancer, Christopher Heeschen, MD, PhD
    • The role of E47 in acinar reprogramming and senescence in PDA, Pamela Itkin-Ansari, PhD
    • Lineage heterogeneity and cellular plasticity in pancreatic ductal adenocarcinoma, Rosalie Sears, PhD

  • Session 2: Metabolism
    • Survival of the fittest: The role of metabolic adaptation in pancreatic cancer, Cosimo Commisso, PhD
    • Lessons from targeting metabolic dependencies in PDAC, Marie Evangelista, PhD
    • Lysosomes and nutrient scavenging in pancreatic cancer, Rushika Perera, PhD


  • Session 3: Cancer Cells and the Microenvironment
    • Deconstructing p53-mediated pancreatic cancer suppression, Laura Attardi, PhD
    • Stromal regulation and therapeutic targeting of the pancreatic cancer epigenome, Mara Sherman, PhD
    • Functional optical probes for dynamic mapping of the chemical and biophysical tumor Microenvironment, Chris DuFort, PhD
  • Session 4: Imaging and Therapeutics
    • avb6 targeted molecular imaging, Julie Sutcliffe, PhD
    • Predictors and kinetics of response in pancreatic cancer, Eric Collison, MD

Abstract Submission

Posters will be presented midday during the expo/lunch session.

Abstract Deadline: Monday, September 5th – 5:00pm PST
All abstracts must be submitted electronically via email.

Questions about abstract submission, please contact Shirley Tejidor at


Andrew M. Lowy, MD
Professor of Surgery
Chief of Surgical Oncology
UC San Diego    

Debbie Soldano NP, MSN, OCN
Nurse Manager
UC San Diego     

Shirley Tejidor, MA
Regional Therapies Program Manager
UC San Diego

Bree Mitchell, PhD
Associate Director, Strategic Partnerships
Oregon Health & Science University

Dove Keith, PhD
Scientific Program Manager
Oregon Health & Science University

Marie Evangelista, PhD
Scientist, Discovery Oncology

Rushika Perea, PhD
Assistant Professor
UC San Francisco

Pamela Itkin-Ansari, PhD
Assistant Professor
Sanford Burnham Prebys Medical Discovery Institute

Christopher Heeschen, MD, PhD
Barts Cancer Institute

Rosalie Sears, PhD
Oregon Health & Science University

Eric Collison, MD
Associate Professor
UC San Francisco

Julie Sutcliffe, PhD
UC Davis

Mara Sherman, PhD
Postdoctoral Fellow
Salk Institute

Cosimo Commisso, PhD
Assistant Professor
Sanford Burnham Prebys Medical Discovery Institute

Laura Attardi, PhD
Stanford Medicine

Chris DuFort, PhD
Post-doctoral Research Associate
Fred Hutchinson Cancer Research Center  

Sunil Hingorani, MD, PhD
Director, Center for Accelerated Translation in Pancreas Cancer
Fred Hutchinson Cancer Research Center  

Registration and Contact Information:

register online

Registration Fee is $100

Refund Information: A refund, less $50 will be allowed if requested on or before September 9, 2016.  No refunds will be allowed after this date.

In the unlikely event that the course is canceled, UC San Diego Continuing Medical Education is responsible only for a full refund of the registration fee and not for transportation, hotel accommodations or any miscellaneous expenses.

For more information, e-mail Shirley Tejidor at


The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Disclosure: It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms: 1) altering the financial relationship with the commercial interest, 2) altering the individual’s control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose will be disqualified from participating in the CME activity.

Cultural and Linguistic Competency: This activity is in compliance with California Assembly Bill 1195 which requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities.  Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or who have limited ability to speak English, direct communication in the patient’s primary language. Cultural and linguistic competency was incorporated into the planning of this activity.  Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UC San Diego Continuing Medical Education website.

Follow UC San Diego CME on    UCSD CME facebook    UCSD CME twitter

UC San Diego School of Medicine, Continuing Medical Education   •  9500 Gilman Drive, MC0947   •  La Jolla, CA 92093-0947
Phone: (858) 534-3940   •   Toll-Free: (888) 229-6263   •   Fax: (858) 534-1896   •  E-mail:   •  Website:

Content is subject to change without notice. Please refer to the activity website for the most current information.
Official website of the University of California, San Diego. Copyright ©2016 Regents of the University of California. All rights reserved.